{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE338nnn/GSE338317/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE338317"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Immune architecture of the colon in ICI-mediated colitis compared with ulcerative colitis","description":"Despite clinical success of immune checkpoint inhibitors (ICI), many cancer patients experience immune-related adverse events (irAEs). Among these, ICI-mediated colitis (IC) is prevalent and is associated with a significant burden on patients and healthcare. Despite resemblance to ulcerative colitis (UC) with respect to clinical symptoms and treatment approaches, IC’s specific causes and cellular mechanisms are incompletely understood.","dates":{"publication":"2026/08/01"},"accession":"GSE338317","cross_references":{"GSM":["GSM9871223","GSM9871225","GSM9871224","GSM9871227","GSM9871226","GSM9871229","GSM9871228","GSM9871230","GSM9871231"],"GPL":["18573"],"GSE":["338317"],"taxon":["Homo sapiens"]}}